EP Patent

EP2429291A1 — Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same

Assigned to Cydex Pharmaceuticals Inc · Expires 2012-03-21 · 14y expired

What this patent protects

The present invention is directed to pharmaceutical compositions comprising prasugrel and a cyclodextrin derivative, and methods of making and using the same.

USPTO Abstract

The present invention is directed to pharmaceutical compositions comprising prasugrel and a cyclodextrin derivative, and methods of making and using the same.

Drugs covered by this patent

Patent Metadata

Patent number
EP2429291A1
Jurisdiction
EP
Classification
—
Expires
2012-03-21
Drug substance claim
No
Drug product claim
No
Assignee
Cydex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.